51 - New Diagnostics, Aegis Ventures, HHS’ Resiliency Plan, Molina and Cityblock, Ozempic’s Growth, Diet as Psychiatric Treatment

Join Marcus & Vic as they discuss the complexities of the healthcare system and the stock market's vagaries. It doesn't stop there; the conversation extends into the terrain of cybersecurity in healthcare, the role of private equity in healthcare provision, and the intriguing potential of dietary approaches to mental health treatment. With a blend of engaging discussions on current trends, policies, and scientific discoveries.

Please check out our Episode Resources below:

------🔎RESOURCES🔎



S&P 500 Drops to Start New Quarter (WSJ) - 2:25

Powell Says Fed Has Time to Assess Data Before Deciding to Cut (Bloomberg) - 4:16

S&P 500 Snaps Two-Day Losing Streak (WSJ) 4:45

What’s Wrong With the Economy? It’s You, Not the Data. (WSJ) - 8:36

Providence spins off patient portal company (Modern Healthcare) - 11.28

Diagnostics company Binx Health banks $65M to drive growth of point-of-care testing (Fierce Healthcare) - 15.02

Investors Put $58 Million Into Biolinq’s Push for Easier Glucose-Monitoring (WSJ)Bolinq website https://www.biolinq.com/ - 18:06

Health tech investor Glen Tullman launches 62 Ventures, a new $100 million fund (Stat) - 20:30

Northwell, Memorial Hermann and others join Aegis Ventures consortium (Modern Healthcare) - 28: 05

Tiger Global VC Fund Closes

HF Site

YOUTUBE
INSTAGRAM
TWITTER
FACEBOOK
LINKEDIN
TIKTOK